Treatment of Oral Biofilms by a D-Enantiomeric Peptide.

Almost all dental diseases are caused by biofilms that consist of multispecies communities. DJK-5, which is a short D-enantiomeric, protease-resistant peptide with broad-spectrum anti-biofilm activity, was tested for its effect on oral multispecies biofilms. Peptide DJK-5 at 10 μg/mL effectively pre...

Full description

Bibliographic Details
Main Authors: Tian Zhang, Zhejun Wang, Robert E W Hancock, César de la Fuente-Núñez, Markus Haapasalo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5120842?pdf=render
id doaj-88cc2c4138bc4eb0ae39755329a54292
record_format Article
spelling doaj-88cc2c4138bc4eb0ae39755329a542922020-11-24T22:03:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011111e016699710.1371/journal.pone.0166997Treatment of Oral Biofilms by a D-Enantiomeric Peptide.Tian ZhangZhejun WangRobert E W HancockCésar de la Fuente-NúñezMarkus HaapasaloAlmost all dental diseases are caused by biofilms that consist of multispecies communities. DJK-5, which is a short D-enantiomeric, protease-resistant peptide with broad-spectrum anti-biofilm activity, was tested for its effect on oral multispecies biofilms. Peptide DJK-5 at 10 μg/mL effectively prevented the growth of these microbes in culture media in a time-dependent manner. In addition to the prevention of growth, peptide DJK-5 completely killed both Streptococcus mutans and Enterococcus faecalis suspended from biofilms after 30 minutes of incubation in liquid culture media. DJK-5 also led to the effective killing of microbes in plaque biofilm. The proportion of bacterial cells killed by 10 μg/mL of DJK-5 was similar after 1 and 3 days, both exceeding 85%. DJK-5 was able to significantly prevent biofilm formation over 3 days (P = 0.000). After 72 hours of exposure, DJK-5 significantly reduced and almost completely prevented plaque biofilm production by more than 90% of biovolume compared to untreated controls (P = 0.000). The proportion of dead biofilm bacteria at the 10 μg/mL DJK-5 concentration was similar for 1- and 3-day-old biofilms, whereby >86% of the bacteria were killed. DJK-5 was also able to kill >79% and >85% of bacteria, respectively, after one-time and three brief treatments of 3-day-old biofilms. The combination of DJK-5 and chlorhexidine showed the best bacterial killing among all treatments, with ~83% and >88% of bacterial cells killed after 1 and 3 minutes, respectively. No significant difference was found in the percentage of biofilm killing amongst three donor plaque samples after DJK-5 treatment. In particular, DJK-5 showed strong performance in inhibiting biofilm development and eradicating pre-formed oral biofilms compared to L-enantiomeric peptide 1018. DJK-5 was very effective against oral biofilms when used alone or combined with chlorhexidine, and may be a promising agent for use in oral anti-biofilm strategies in the future.http://europepmc.org/articles/PMC5120842?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Tian Zhang
Zhejun Wang
Robert E W Hancock
César de la Fuente-Núñez
Markus Haapasalo
spellingShingle Tian Zhang
Zhejun Wang
Robert E W Hancock
César de la Fuente-Núñez
Markus Haapasalo
Treatment of Oral Biofilms by a D-Enantiomeric Peptide.
PLoS ONE
author_facet Tian Zhang
Zhejun Wang
Robert E W Hancock
César de la Fuente-Núñez
Markus Haapasalo
author_sort Tian Zhang
title Treatment of Oral Biofilms by a D-Enantiomeric Peptide.
title_short Treatment of Oral Biofilms by a D-Enantiomeric Peptide.
title_full Treatment of Oral Biofilms by a D-Enantiomeric Peptide.
title_fullStr Treatment of Oral Biofilms by a D-Enantiomeric Peptide.
title_full_unstemmed Treatment of Oral Biofilms by a D-Enantiomeric Peptide.
title_sort treatment of oral biofilms by a d-enantiomeric peptide.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Almost all dental diseases are caused by biofilms that consist of multispecies communities. DJK-5, which is a short D-enantiomeric, protease-resistant peptide with broad-spectrum anti-biofilm activity, was tested for its effect on oral multispecies biofilms. Peptide DJK-5 at 10 μg/mL effectively prevented the growth of these microbes in culture media in a time-dependent manner. In addition to the prevention of growth, peptide DJK-5 completely killed both Streptococcus mutans and Enterococcus faecalis suspended from biofilms after 30 minutes of incubation in liquid culture media. DJK-5 also led to the effective killing of microbes in plaque biofilm. The proportion of bacterial cells killed by 10 μg/mL of DJK-5 was similar after 1 and 3 days, both exceeding 85%. DJK-5 was able to significantly prevent biofilm formation over 3 days (P = 0.000). After 72 hours of exposure, DJK-5 significantly reduced and almost completely prevented plaque biofilm production by more than 90% of biovolume compared to untreated controls (P = 0.000). The proportion of dead biofilm bacteria at the 10 μg/mL DJK-5 concentration was similar for 1- and 3-day-old biofilms, whereby >86% of the bacteria were killed. DJK-5 was also able to kill >79% and >85% of bacteria, respectively, after one-time and three brief treatments of 3-day-old biofilms. The combination of DJK-5 and chlorhexidine showed the best bacterial killing among all treatments, with ~83% and >88% of bacterial cells killed after 1 and 3 minutes, respectively. No significant difference was found in the percentage of biofilm killing amongst three donor plaque samples after DJK-5 treatment. In particular, DJK-5 showed strong performance in inhibiting biofilm development and eradicating pre-formed oral biofilms compared to L-enantiomeric peptide 1018. DJK-5 was very effective against oral biofilms when used alone or combined with chlorhexidine, and may be a promising agent for use in oral anti-biofilm strategies in the future.
url http://europepmc.org/articles/PMC5120842?pdf=render
work_keys_str_mv AT tianzhang treatmentoforalbiofilmsbyadenantiomericpeptide
AT zhejunwang treatmentoforalbiofilmsbyadenantiomericpeptide
AT robertewhancock treatmentoforalbiofilmsbyadenantiomericpeptide
AT cesardelafuentenunez treatmentoforalbiofilmsbyadenantiomericpeptide
AT markushaapasalo treatmentoforalbiofilmsbyadenantiomericpeptide
_version_ 1725832012868091904